Dieter Weinand's most recent trade in Replimune Group Inc was a trade of 32,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Replimune Group Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 32,000 | 32,000 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Coya Therapeutics Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2023 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 37,800 | 37,800 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 24,750 | 24,750 | - | - | Stock Option (right to buy) | |
Replimune Group Inc | Dieter Weinand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 24,750 | 24,750 | - | - | Stock Option (right to buy) |